Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSS0393 Ointment in pediatric plaque psoriasis
NCT07102888Phase 2Not yet recruiting
- Sponsor
- Hengrui
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RSS0393 in plaque psoriasis, sponsored by Hengrui. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
RSS0393
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07102888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07102888.